Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Prednisolone for Adrenal Crisis
NCT05639127Phase 1Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2022
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of prednisolone in adrenal insufficiency (AI), sponsored by University Medical Center Groningen. Primary endpoints: Time to Maximum Concentration at 4 hours and Area Under the Curve at 4 hours. Status: unknown.
02
Drugs
prednisolone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT05639127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05639127.